MoneyWorks4Me

Lupin informs about press release

21 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding receipt of US FDA approval for the Company’s Abbreviated New Drug Application for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg, to market a generic equivalent of Livalo Tablets, 1 mg, 2 mg, and 4 mg, of Kowa Company. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1803.60
Dr. Reddys Labs. 1213.70
Cipla 1344.15
Lupin 2012.05
Zydus Lifesciences 1135.45
View more..